(6& … · - philips : 3d echocardiography. (2016) - servier : clinical case presentation...

30
Baumgartner Helmut A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Gore : Occluders for shunt closure (2015) - St. Jude Medical : Occluders for shunt closure (ASD, PFO, PDA, VSD) (2015) - Abbott : transcather mitral valve repair (Mitraclip) (2015) - Direct Flow Medical : transcatheter valve implantation (2015) - Actelion : Bosentan and Macicentan for PAH treatment in congenital heart disease (2015-2016) - Edwards Lifesciences : transcatheter valve implantation (2015-2016) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Gore : Occluders for shunt closure (2015) - St. Jude Medical : Occluders for shunt closure (ASD, PFO, PDA, VSD) (2015) - Direct Flow Medical : transcatheter valve implantation (2015) - Actelion : Bosentan for PAH treatment in congenital heart disease (2015-2016) - Abbott : transcather mitral valve repair (Mitraclip) (2015-2016) - Edwards Lifesciences : transcatheter valve implantation (2015-2016) - Medtronic Foundation : transcatheter valve implantation (2016) Bax Jeroen Nothing to be declared (2015-2016) De Bonis Michele A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : valve prostheses (2015-2016) Falk Volkmar B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Berlin Heals : cell modification (2015) - Boston Scientific : heart valves (2015-2016) - Edwards Lifesciences : heart valves (2015-2016) - Medtronic : heart valves (2015-2016) - Aesculap : minimally invasive mitral surgery (2015-2016) 21/08/2017 Expert Type of Relationship with Industry 2017 ESC/EACTS Guidelines for the management of valvular heart disease - Task Force Members For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016. 1/30

Upload: others

Post on 06-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Baumgartner Helmut A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Gore : Occluders for shunt closure (2015)

- St. Jude Medical : Occluders for shunt closure (ASD, PFO, PDA, VSD) (2015)

- Abbott : transcather mitral valve repair (Mitraclip) (2015)

- Direct Flow Medical : transcatheter valve implantation (2015)

- Actelion : Bosentan and Macicentan for PAH treatment in congenital heart disease (2015-2016)

- Edwards Lifesciences : transcatheter valve implantation (2015-2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Gore : Occluders for shunt closure (2015)

- St. Jude Medical : Occluders for shunt closure (ASD, PFO, PDA, VSD) (2015)

- Direct Flow Medical : transcatheter valve implantation (2015)

- Actelion : Bosentan for PAH treatment in congenital heart disease (2015-2016)

- Abbott : transcather mitral valve repair (Mitraclip) (2015-2016)

- Edwards Lifesciences : transcatheter valve implantation (2015-2016)

- Medtronic Foundation : transcatheter valve implantation (2016)

Bax Jeroen Nothing to be declared (2015-2016)

De Bonis Michele A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : valve prostheses (2015-2016)

Falk Volkmar B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Berlin Heals : cell modification (2015)

- Boston Scientific : heart valves (2015-2016)

- Edwards Lifesciences : heart valves (2015-2016)

- Medtronic : heart valves (2015-2016)

- Aesculap : minimally invasive mitral surgery (2015-2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - Task Force MembersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conductedevery January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up toand including 2016.

1/30

Page 2: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Falk Volkmar D - Research funding (departmental or institutional).- Philips : Imaging (2015-2016)

- Heartware : LVAD (2015-2016)

- SJM : VAD Therapy (2016)

Hamm Christian A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : drugs (2015-2016)

- Boehringer-Ingelheim : drugs (2015-2016)

- Daiichi Sankyo : drugs (2015-2016)

- Novartis : drugs (2015-2016)

- Pfizer : drugs (2015-2016)

- Sanofi Aventis : drugs (2015-2016)

- GlaxoSmithKline : drugs (2015-2016)

- Lilly : drugs (2015-2016)

- Heart.org : drugs (2015-2016)

- Bayer Healthcare : drugs (2015-2016)

- Medicines Company : drugs (2015-2016)

- Merck Sharp & Dohme : drugs (2015-2016)

- Abbott Vascular : interventional devices (2015-2016)

- BRAHMS GmbH : markers (2015-2016)

- Siemens Healthcare : MRI (2015-2016)

- Boston Scientific : PCI (2015-2016)

- Medtronic : PCI, Valves (2015-2016)

- TIMI group : study advisor (2015-2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - Task Force MembersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conductedevery January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up toand including 2016.

2/30

Page 3: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Hamm Christian D - Research funding (departmental or institutional).- Deutsche Forschungsgemeinschaft : experimental (2015-2016)

- German Research Foundation : experimental studies (2015-2016)

Holm Per Johan Nothing to be declared (2016)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Actelion : PAH (2015)

Iung Bernard A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : dabigatran (2015)

- Edwards Lifesciences : heart valve prosthesis (2015)

- Edwards Lifesciences : Heart Valve Prostheses (2016)

Lancellotti Patrizio A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Imaging Ischemic disease (2015)

- Boston Scientific : Sudden death (2015)

- St Jude Medical : Echo course (2015-2016)

- Servier : Ischemic Heart Disease (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : NOAC (2015-2016)

- Medtronic : Structural disease (2016)

Lansac Emmanuel A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : speaker fees (2015)

- Vascutek Ltd : Speakers fees (2015)

- Edwards Lifesciences : speakers fees (2015-2016)

C - Receipt of royalties for intellectual property.- Coroneo Inc : Aortic ring (2015)

Rodriguez Munoz Daniel Nothing to be declared (2015-2016)

Rosenhek Raphael A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sorin Group : Valvular heart disease (2015)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - Task Force MembersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conductedevery January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up toand including 2016.

3/30

Page 4: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Rosenhek Raphael - Abbott : Valvular heart disease (2015-2016)

- Edwards Lifesciences : Valvular heart disease (2015-2016)

- Valtech : Valvular heart disease (2015-2016)

- LIvanova : Valvular heart disease (2016)

Sjogren Johan Nothing to be declared (2015-2016)

Tornos Mas Pilar Nothing to be declared (2016)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Recordati International : Lipazo (2015)

- Edwards Lifesciences : Transtcatheter aortic valves (2015)

Vahanian Alec A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : valve disease (2015-2016)

- Edwards Lifesciences : valve disease (2015-2016)

- Valtech : valve disease (2015-2016)

Walther Thomas B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Edwards Lifesciences : TAVI (2015-2016)

- St Jude Medical : tAVI (2015-2016)

- Symetis SA : TAVI (2015-2016)

Wendler Olaf A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott Laboratories : Advisory Board on Mitral Valve Technology (2015)

- Cardiosolutions : Mitral Valve Repair Device Development (2015)

- JenaValve Technology : Transcatheter Heart Valves Registry (2015)

- Edwards Lifesciences : Transcatheter Heart valves, Heart Failure Device Development (2015)

- Edwards Lifesciences : TAVI (2016)

D - Research funding (departmental or institutional).- Edwards Lifesciences : TAVI Registries and Trials (2015)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - Task Force MembersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conductedevery January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up toand including 2016.

4/30

Page 5: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Wendler Olaf - Edwards Lifesciences : TAVI Registry (2016)

- Neovasc : Transcatheter mitral valve therapy feasibility trial (2016)

Windecker Stephan A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Antiplatelet therapy (2015)

- Daiichi Sankyo : Antiplatelet therapy (2015)

- Boston Scientific : Complex PCI (2015)

- Sanofi Aventis : Managing Dyslipidemia (2015)

D - Research funding (departmental or institutional).- Sorin Group : Electrophysiology (2015)

- Biotronik : Electrophysiology (2015)

- Johnson & Johnson : Electrophysiology and PCI (2015)

- Guerbet : Imaging (2015)

- Novartis : IMP (2015)

- Actelion : IMP (2015)

- Medicines Company : IMP (2015)

- Merck Sharp & Dohme : IMP (2015)

- St Jude Medical : PCI (2015)

- Abbott : PCI and Structural Heart Disease (2015)

- Boston Scientific : Structural Heart Disease (2015)

- Edwards Lifesciences : Structural Heart Disease (2015)

- Symetis SA : Structural Heart Disease (2015)

- Medtronic : Structural Heat Disease (2015)

- Boston Scientific : General Cardiology (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - Task Force MembersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conductedevery January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up toand including 2016.

5/30

Page 6: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Windecker Stephan - St Jude Medical : General Cardiology (2016)

- Terumo Inc : General Cardiology (2016)

- Bracco Pharmaceutical : General Cardiology (2016)

Zamorano Gomez Jose Luis

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- MSD : CV risk factors (2015)

- Abbott : Lecturing (2015)

- Pfizer : Lecturing (2015)

- Sorin Group : Respicardia echo protocol (2015)

- Philips : 3D Echocardiography. (2016)

- Servier : Clinical case presentation during ESC Cong 2016 (2016)

- Pfizer : speaker CV risk factors. (2016)

- MSD : speaker. CV risk factors (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Siemens Healthcare : 3d echo software and free style echo (2015)

- Toshiba medical imaging : Fusion Imaging (2015)

D - Research funding (departmental or institutional).- Amgen : Clinical trial (2015)

- Novartis : Clinical trial (2015)

- Ikaria : Clinical trial (2015)

- Edwards Lifesciences : Echo for TAVi assessment & Epidemiology of Ao stenosis (2016)

- Abbott : Epidemiology study of Mitral regurgitation (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - Task Force MembersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conductedevery January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up toand including 2016.

6/30

Page 7: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Abdelhamid Magdy Nothing to be declared (2016)

Aboyans Victor A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Amgen : Hyperlipidemia (2016)

- Novartis : Hypertension (2016)

- Boehringer-Ingelheim : Oral anticoagulation (2016)

- Bayer Healthcare : Oral anticoagulation (2016)

- Pfizer/BMS alliance : Oral anticoagulation (2016)

Agewall Stefan A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Antiplatelet treatment (2016)

Ahlsson Anders A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sanofi Aventis : Atrial fibrillation symposium speakers fee year 2008: 500 Euro (2016)

D - Research funding (departmental or institutional).- Swedish Society of Medicine : Financial support for studies (2016)

- Örebro university hospital Research committee : Financial support for studies years 2008-2013 (2016)

- Vingmed / Estech : Microwave ablation study year 2008: 5000 Euro (2016)

Alfieri Ottavio Nothing to be declared (2016)

Bajraktari Gani Nothing to be declared (2016)

Bakhutashvili Zviad Nothing to be declared (2016)

Barbato Emanuele B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : Education courses on rotational atherectomy (2016)

- St Jude Medical : Educational courses on FFR (2016)

D - Research funding (departmental or institutional).- St Jude Medical : Unrestricted grant for an investigator-driven study (2016)

Bouma Berto A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott Vascular : mitraclip (2016)

Bozkurt Engin B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Amgen : Advisory Board fees (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

7/30

Page 8: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Bozkurt Engin - Astra Zeneca : Advisory Board fees (2016)

- Edwards Lifesciences : Proctoring fees (2016)

- Boehringer-Ingelheim : Speaker fees (2016)

Branco Luisa Maria De Moura

Nothing to be declared (2016)

Brecker Stephen Jon David A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : Transcatheter Valves (2016)

- Medtronic : Transcatheter Valves (2016)

D - Research funding (departmental or institutional).- Medtronic : Transcatheter Valves (2016)

Bueno Hector A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Pfizer : Apixaban (2016)

- Bristol Myers Squibb : Apixaban (2016)

- Bayer : Aspirin, rivaroxaban (2016)

- Abbott : BVS (2016)

- MEDSCAPE-the heart.og : Inespecific (2016)

- Servier : ivabradine (2016)

- Novartis : Serelaxin, ACZ885, AHF Academy (2016)

- Astra Zeneca : Ticagrelor (2016)

- Ferrer Internacional : Trinomia (polypill) (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Ticagrelor (2016)

E - Research funding (personal).- BMS : CV013-011 - STANDUP-AHF trial (2016)

- Novartis : LCZ696 - PROMISE / PERSPECTIVE (2016)

- Janssen-Cilag : Rivaroxaban - GEMINI ACS Trials 1 & 2 (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

8/30

Page 9: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Bueno Hector - Astra Zeneca : Ticagrelor - EPICOR Study, THEMIS trial (2016)

Bunc Matjaz A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Edwards Lifesciences : TAVI, proctor (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : TAVI, proctor (2016)

Cassar Demarco Daniela Nothing to be declared (2016)

Cohen Ariel A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bristol Myers Squibb : apixaban (2016)

- Boehringer-Ingelheim : dabigatran (2016)

- Daiichi Sankyo : edoxaban (2016)

- Novartis : entresto (2016)

- Bayer Healthcare : rivaroxaban (2016)

Collet Jean-Philippe A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- BMS : apixaban (2016)

- Sanofi Aventis : CLOPIDOGREL (2016)

- Medtronic : corevalve (2016)

- Eli Lilly : PRASUGREL (2016)

- Astra-Zeneca : ticagrelor (2016)

- MSD : VORAPAXAR (2016)

- Bayer Healthcare : xarelto (2016)

D - Research funding (departmental or institutional).- Bristol Myers Squibb : APIXABAN (2016)

- Medtronic : COREVALVE (2016)

- Stago : LABORATORY TEST (2016)

- Eli Lilly : PRASUGREL (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

9/30

Page 10: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Collet Jean-Philippe - FEDERATION FRANCAISE DE CARDIOLOGIE : THROMBOSIS (2016)

- ICAN : THROMBOSIS (2016)

- Astra Zeneca : TICAGRELOR (2016)

Coman Ioan Mircea A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : anticoagulants (2016)

- Johnson & Johnson : antithrombotic (2016)

- Bayer AG : antithrombotic (2016)

- Sanofi Aventis : dyslipidemia (2016)

- Fournier Laboratories : dyslipidemia (2016)

- Amgen Inc : dyslipidemia , (2016)

- Novartis : HF (2016)

- Vifor International : iron deficiency (2016)

- Actelion : PHT (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : anticoagulants (2016)

- Johnson & Johnson : antithrombotic (2016)

- Bayer AG : antithrombotic (2016)

- Sanofi Aventis : dyslipidemia (2016)

- Amgen Inc : dyslipidemia (2016)

- Fournier Laboratories : dyslipidemia (2016)

- Novartis : HF (2016)

- Vifor International : iron deficiency (2016)

- Actelion : PHT (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

10/30

Page 11: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Czerny Martin A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Vascutek Ltd : Classical surgery (2016)

- Medtronic : TEVAR (2016)

- Bolton Medical : TEVAR (2016)

Delgado Victoria A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott Vascular : Mitraclip (2016)

D - Research funding (departmental or institutional).- Boston Scientific : Pacemaker-Heart failure (2016)

- Medtronic : Pacemaker-Heart failure (2016)

- Biotronik : Pacemaker-Heart Failure (2016)

- Edwards Lifesciences : Valvular heart disease (2016)

Fitzsimons Donna Nothing to be declared (2016)

Folliguet Thierry A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- LIvanova : valve (2016)

Foscoli Marina Nothing to be declared (2016)

Gaemperli Oliver A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- GE-Healthcare : Imaging (2016)

- Amgen Inc : PCSK9 (2016)

- Servier : Procorolan (2016)

Georgiou Georgios M Nothing to be declared (2016)

Gudnason Thorarinn Nothing to be declared (2016)

Habib Gilbert A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Actelion : pulmonary hypertension (2016)

Harringer Wolfgang B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Terumo Inc : Specialist training in minibypass systems (2016)

Haude Michael A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Lilly : anti platelet therapy (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

11/30

Page 12: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Haude Michael - Abbott : BVS, MitraClip (2016)

- Volcano : IVUS (2016)

- Biotronik : PCI (2016)

- Cardiac Dimensions : structual heart interventions (2016)

D - Research funding (departmental or institutional).- Abbott : scaffold (2016)

- Biotronik : scaffold (2016)

- Cardiac Dimensions : structural heart intervention (2016)

Hindricks Gerhard B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : CIEDs and interventional electrophysiology (2016)

- St Jude Medical : CIEDs and interventional electrophysiology (2016)

- Biotronik : CIEDs and interventional electrophysiology (2016)

D - Research funding (departmental or institutional).- Boston Scientific : CIEDs and interventional electrophysiology (2016)

- St Jude Medical : CIEDs and interventional electrophysiology (2016)

Ihlemann Nikolaj Nothing to be declared (2016)

Ince Hueseyin A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : MitraClip (2016)

- Astra Zeneca : pharmaceutical product (2016)

- Bayer : pharmaceutical product (2016)

- Daiichi Sankyo : pharmaceutical product (2016)

- Pfizer : pharmaceutical product (2016)

- Bristol Myers Squibb : pharmaceutical product (2016)

- Boston Scientific : TAVI (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

12/30

Page 13: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Ince Hueseyin - Direct Flow Medical : TAVI (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : MitraClip and scaffold (2016)

- Boston Scientific : TAVI (2016)

Indolfi Ciro A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : endovascular devices (2016)

- Edwards Lifesciences : endovascular devices (2016)

- Medtronic : endovascular devices (2016)

Jovovic Ljiljana Nothing to be declared (2016)

Katus Hugo A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : Lixiana_NOAK (2016)

- Astra Zeneca : Ticagrelor (2016)

- Bayer Vital : Xarelto-NOAK (2016)

D - Research funding (departmental or institutional).- St Jude Medical : Biobank (2016)

- Philips : MRT (2016)

Kaufmann Beat Andreas Nothing to be declared (2016)

Kerimkulova Alina Nothing to be declared (2016)

Knuuti Juhani D - Research funding (departmental or institutional).- Orion : Brain diseases (2016)

- AC Immune : Brain diseses (2016)

- Antaros : Endocrinology (2016)

- Boehringer-Ingelheim : Neurology (2016)

- MSD : Neurology (2016)

- GE Gealthcare : Neurology (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

13/30

Page 14: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Kolh Philippe H A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Antiplatelet agents (2016)

- B.Braun : Surgical instruments (2016)

Komar Monika Nothing to be declared (2016)

Kuperstein Rafael Nothing to be declared (2016)

Kzhdryan Hovhannes Nothing to be declared (2016)

Lebrun Frederic A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer Healthcare : Rivaroxaban (2016)

Leclercq Christophe A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : devices (2016)

- Medtronic : devices (2016)

- Sorin Group : devices (2016)

- St Jude Medical : devices (2016)

- Biotronik : devices (2016)

- Bayer Healthcare : DOAC (2016)

Linhartova Katerina B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Novartis : cardiology (2016)

Loncar Daniela Nothing to be declared (2016)

Lovric Daniel A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- PharmaSwiss : Acetyl Salicylic Acid (2016)

- Servier : Arterial Hypertension (2016)

- Sandoz : Arterial Hypertension (2016)

- Boehringer-Ingelheim : Atrial Fibrillation (2016)

- Bayer AG : Atrial Fibrillation (2016)

- PharmaS : Cardiac Intensive Care Sepsis Management (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

14/30

Page 15: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Lovric Daniel - Merck Serono : Ischaemic Heart Disease and Diabetes (2016)

- Medis Adria : Levosimendan (2016)

Mahdhaoui Abdallah Nothing to be declared (2016)

Mascherbauer Julia A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : NOAC (2016)

- Merck Sharp & Dohme : Pulmonary hypertension (2016)

- AOP Orphan Pharmaceuticals : Pulmonary hypertension (2016)

McDonagh Theresa A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Vifor International : Ferrinject (2016)

- Novartis : Honoraria (2016)

Mizariene Vaida Nothing to be declared (2016)

Mylotte Darren A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : Interventional Cardiology (2016)

- Medtronic : Interventional Cardiology (2016)

- Microport : Interventional Cardiology (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biosensors : Interventional Cardiology (2016)

- Medtronic : Interventional Cardiology (2016)

Nesukay Elena A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : cardiology (2016)

Oukerraj Latifa Nothing to be declared (2016)

Pern Teele A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Myocardial infarction (2016)

Piepoli Massimo Francesco A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Committee member, Speaker fee (2016)

- Novartis : Heart Failure Prevention Initiatives, Advisory Board (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

15/30

Page 16: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Piepoli Massimo Francesco - Amgen : Metabolic, Lipid (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Novartis : Heart Failure Prevention Initiatives (2016)

Pierard Luc A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biotronik : Speaker fee (2016)

- Boehringer-Ingelheim : Speaker fees, Advisory Board (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Sponsorship Annual meeting (2016)

- Daiichi Sankyo : Sponsorship Echocardiography course (2016)

- St Jude Medical : Sponsorship Echocardiography course (2016)

D - Research funding (departmental or institutional).- Biotronik : Research funding (2016)

Ponikowski Piotr A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : anticoagulant, diabetes (2016)

- Abbott Vascular : devices (2016)

- Respicardia : devices (2016)

- BioControl : devices (2016)

- Novartis : heart failure (2016)

- Cardiorentis : heart failure (2016)

- Berlin Chemie AG : heart failure (2016)

- Bayer Healthcare : heart failure (2016)

- Vifor Pharma ltd : heart failure (2016)

- CIBIEM : heart failure (2016)

- Servier : heart failure, coronary artery disease (2016)

- Amgen : heart failure, lipids (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

16/30

Page 17: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Ponikowski Piotr - Pfizer : lipids (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Respicardia : anticoagulant (2016)

- BioControl : devices (2016)

- DC Device : devices (2016)

- Novartis : heart failure (2016)

- Cardiorentis : heart failure (2016)

- Bayer Healthcare : heart failure (2016)

- CIBIEM : heart failure (2016)

- Servier : heart failure, coronary artery disease (2016)

- Amgen : heart failure, lipids (2016)

Popescu Bogdan Alexandru A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- GE Healthcare : Imaging (2016)

Pya Yuriy Nothing to be declared (2016)

Roffi Marco A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Terumo Inc : coronary catheters (2016)

- Johnson & Johnson : coronary catheters (2016)

- Astra Zeneca : speaker fees related to the 2015 ESC NSTEMI GL (2016)

D - Research funding (departmental or institutional).- Boston Scientific : devices (2016)

- Medtronic : devices (2016)

- Biotronik : devices (2016)

- Terumo Inc : devices (2016)

- Abbott Vascular : devices (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

17/30

Page 18: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Rosano Giuseppe M C Nothing to be declared (2016)

Rudzitis Ainars A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Arterial Hypertension (2016)

- Berlin Menarini : CAD (2016)

- Shire HGT : Fabry disease (2016)

- Genzyme : Fabry disease (2016)

- Boehringer-Ingelheim : NOACs (2016)

Ruschitzka Frank A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Amgen : Drug (2016)

- Novartis : Drug (2016)

- Pfizer : Drug (2016)

- BMS : Drug (2016)

- Servier : Drugs (2016)

- Sanofi Aventis : Drugs (2016)

- Zoll Medical : LifeVest (2016)

- St. Jude Medical : Medical devices (2016)

- Fresenius Nutrition : Steering Committee Meetings of Clinical Trials (2016)

- Vifor International : Steering Committee Meetings of Clinical Trials (2016)

- Cardiorentis : TRUE-AHF Steering Committee (2016)

- Heartware : Ventricular assist devices (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : Postgraduate Heart Failure Course (Grant to Zurich Heart House) (2016)

- Novartis : Postgraduate Heart Failure Course (Grant to Zurich Heart House) (2016)

- St Jude Medical : Postgraduate Heart Failure Course (Grant to Zurich Heart House) (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

18/30

Page 19: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Ruschitzka Frank D - Research funding (departmental or institutional).- Mars : Flavanol-like cocoa products (2016)

Samadov Fuad Nothing to be declared (2016)

Shlyakhto Evgeny A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Krka Pharma : Arterial Hypertension (2016)

- Novartis : Arterial Hypertension, Heart Failure (2016)

- Merck Sharp & Dohme : Atherosclerosis (2016)

- Boehringer-Ingelheim : Dabigatran for Atrial Fibrillation (2016)

- Pfizer : General Cardiology (2016)

Shumavets Vadim Nothing to be declared (2016)

Simkova Iveta A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Pfizer : apixaban (2016)

- Merck Serono : bisoprolol (2016)

- Actelion : bosentan, macitentan (2016)

- Merck Sharp & Dohme : riociguat (2016)

- AOP Orphan Pharmaceuticals : treprostinil (2016)

Simpson Iain A Nothing to be declared (2016)

Sousa Uva Miguel A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : Dabigatran (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Ticagrelor (2016)

Srbinovska-Kostovska Elizabeta

Nothing to be declared (2016)

Stagmo Martin A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : General Cardiology (2016)

Steigen Terje Kristian Nothing to be declared (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

19/30

Page 20: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Stepinska Janina A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : antiplatelet therapy (2016)

- Polpharma : heart failure (2016)

- Novartis : heart failure/seralaxin, sacubitril/valsartan (2016)

- Zoll Medical : hypothermia/STEMI (2016)

- Pfizer : NOACs/apixapan (2016)

- Boehringer-Ingelheim : NOACs/dabigatran (2016)

- Bayer : NOACs/rivaroxaban (2016)

- Amgen : PCSK9 inhibitors (2016)

- Sanofi Aventis : PCSK9 inhibitors (2016)

- Servier : stable angina/registry (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Novartis : acute heart failure/seralaxine (2016)

- Bayer : atrial fibillation, heart failure, rivaroxaban (2016)

- Cardiorentis : heart failure (2016)

- Zoll Medical : hypothermia/STEMI (2016)

Tarantini Giuseppe A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Interventional Cardiology (2016)

- Boston Scientific : Interventional Cardiology (2016)

- Edwards Lifesciences : Interventional Cardiology (2016)

- Medtronic : Interventional Cardiology (2016)

- St Jude Medical : Interventional Cardiology (2016)

- Abbott Vascular : Interventional Cardiology (2016)

- Volcano : Interventional Cardiology (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

20/30

Page 21: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Tchetche Didier A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : consulting (2016)

- Boston Scientific : Consulting (2016)

- Edwards Lifesciences : consulting (2016)

- Medtronic : Consulting (2016)

Temesvari Andras A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Lilly : Pulmonary arteriail hypertension (2016)

- Actelion : pulmonary arterial hypertension (2016)

Turpeinen Anu Nothing to be declared (2016)

Uspenskiy Vladimir Nothing to be declared (2016)

Van Camp Guy B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : Pradaxa (2016)

Vavouranakis Emmanouil A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Proctor (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : antiplatelet (2016)

Vazquez De Prada Tiffe Jose Antonio

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Pfizer : ORAL ANTICOAGULATION (2016)

21/08/2017

Expert Type of Relationship with Industry

2017 ESC/EACTS Guidelines for the management of valvular heart disease - ReviewersFor ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

21/30

Page 22: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Aboyans Victor A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Amgen : Hyperlipidemia (2016)

- Novartis : Hypertension (2016)

- Boehringer-Ingelheim : Oral anticoagulation (2016)

- Bayer Healthcare : Oral anticoagulation (2016)

- Pfizer/BMS alliance : Oral anticoagulation (2016)

Agewall Stefan A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Antiplatelet treatment (2016)

Barbato Emanuele B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : Education courses on rotational atherectomy (2016)

- St Jude Medical : Educational courses on FFR (2016)

D - Research funding (departmental or institutional).- St Jude Medical : Unrestricted grant for an investigator-driven study (2016)

Bueno Hector A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Pfizer : Apixaban (2016)

- Bristol Myers Squibb : Apixaban (2016)

- Bayer : Aspirin, rivaroxaban (2016)

- Abbott : BVS (2016)

- MEDSCAPE-the heart.og : Inespecific (2016)

- Servier : ivabradine (2016)

- Novartis : Serelaxin, ACZ885, AHF Academy (2016)

- Astra Zeneca : Ticagrelor (2016)

- Ferrer Internacional : Trinomia (polypill) (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Ticagrelor (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

22/30

Page 23: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Bueno Hector E - Research funding (personal).- BMS : CV013-011 - STANDUP-AHF trial (2016)

- Novartis : LCZ696 - PROMISE / PERSPECTIVE (2016)

- Janssen-Cilag : Rivaroxaban - GEMINI ACS Trials 1 & 2 (2016)

- Astra Zeneca : Ticagrelor - EPICOR Study, THEMIS trial (2016)

Coca Antonio A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Merck Serono : Bisoprolol-Amlodipine (2016)

- Menarini : Nevibolol; Olmesartan; Olmesartan-Amlodipine; Olmesartan-HCTZ (2016)

- Boehringer-Ingelheim : Telmisartan; Telmisartan-Amlodipine; Telmisartan-HCTZ (2016)

- Ferrer Internacional : Torasemide; CardioIncode microchips; Polypill (2016)

Collet Jean-Philippe A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- BMS : apixaban (2016)

- Sanofi Aventis : CLOPIDOGREL (2016)

- Medtronic : corevalve (2016)

- Eli Lilly : PRASUGREL (2016)

- Astra-Zeneca : ticagrelor (2016)

- MSD : VORAPAXAR (2016)

- Bayer Healthcare : xarelto (2016)

D - Research funding (departmental or institutional).- Bristol Myers Squibb : APIXABAN (2016)

- Medtronic : COREVALVE (2016)

- Stago : LABORATORY TEST (2016)

- Eli Lilly : PRASUGREL (2016)

- FEDERATION FRANCAISE DE CARDIOLOGIE : THROMBOSIS (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

23/30

Page 24: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Collet Jean-Philippe - ICAN : THROMBOSIS (2016)

- Astra Zeneca : TICAGRELOR (2016)

Coman Ioan Mircea A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : anticoagulants (2016)

- Johnson & Johnson : antithrombotic (2016)

- Bayer AG : antithrombotic (2016)

- Sanofi Aventis : dyslipidemia (2016)

- Fournier Laboratories : dyslipidemia (2016)

- Amgen Inc : dyslipidemia , (2016)

- Novartis : HF (2016)

- Vifor International : iron deficiency (2016)

- Actelion : PHT (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : anticoagulants (2016)

- Johnson & Johnson : antithrombotic (2016)

- Bayer AG : antithrombotic (2016)

- Sanofi Aventis : dyslipidemia (2016)

- Amgen Inc : dyslipidemia (2016)

- Fournier Laboratories : dyslipidemia (2016)

- Novartis : HF (2016)

- Vifor International : iron deficiency (2016)

- Actelion : PHT (2016)

Delgado Victoria A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott Vascular : Mitraclip (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

24/30

Page 25: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Delgado Victoria D - Research funding (departmental or institutional).- Boston Scientific : Pacemaker-Heart failure (2016)

- Medtronic : Pacemaker-Heart failure (2016)

- Biotronik : Pacemaker-Heart Failure (2016)

- Edwards Lifesciences : Valvular heart disease (2016)

Fitzsimons Donna Nothing to be declared (2016)

Gaemperli Oliver A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- GE-Healthcare : Imaging (2016)

- Amgen Inc : PCSK9 (2016)

- Servier : Procorolan (2016)

Hindricks Gerhard B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : CIEDs and interventional electrophysiology (2016)

- St Jude Medical : CIEDs and interventional electrophysiology (2016)

- Biotronik : CIEDs and interventional electrophysiology (2016)

D - Research funding (departmental or institutional).- Boston Scientific : CIEDs and interventional electrophysiology (2016)

- St Jude Medical : CIEDs and interventional electrophysiology (2016)

Iung Bernard A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Edwards Lifesciences : Heart Valve Prostheses (2016)

Juni Peter Nothing to be declared (2016)

Katus Hugo A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : Lixiana_NOAK (2016)

- Astra Zeneca : Ticagrelor (2016)

- Bayer Vital : Xarelto-NOAK (2016)

D - Research funding (departmental or institutional).- St Jude Medical : Biobank (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

25/30

Page 26: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Katus Hugo - Philips : MRT (2016)

Knuuti Juhani D - Research funding (departmental or institutional).- Orion : Brain diseases (2016)

- AC Immune : Brain diseses (2016)

- Antaros : Endocrinology (2016)

- Boehringer-Ingelheim : Neurology (2016)

- MSD : Neurology (2016)

- GE Gealthcare : Neurology (2016)

Lancellotti Patrizio A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : Echo course (2016)

- Servier : Ischemic Heart Disease (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : NOAC (2016)

- Medtronic : Structural disease (2016)

Leclercq Christophe A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : devices (2016)

- Medtronic : devices (2016)

- Sorin Group : devices (2016)

- St Jude Medical : devices (2016)

- Biotronik : devices (2016)

- Bayer Healthcare : DOAC (2016)

McDonagh Theresa A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Vifor International : Ferrinject (2016)

- Novartis : Honoraria (2016)

Piepoli Massimo Francesco A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Committee member, Speaker fee (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

26/30

Page 27: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Piepoli Massimo Francesco - Novartis : Heart Failure Prevention Initiatives, Advisory Board (2016)

- Amgen : Metabolic, Lipid (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Novartis : Heart Failure Prevention Initiatives (2016)

Ponikowski Piotr A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : anticoagulant, diabetes (2016)

- Abbott Vascular : devices (2016)

- Respicardia : devices (2016)

- BioControl : devices (2016)

- Novartis : heart failure (2016)

- Cardiorentis : heart failure (2016)

- Berlin Chemie AG : heart failure (2016)

- Bayer Healthcare : heart failure (2016)

- Vifor Pharma ltd : heart failure (2016)

- CIBIEM : heart failure (2016)

- Servier : heart failure, coronary artery disease (2016)

- Amgen : heart failure, lipids (2016)

- Pfizer : lipids (2016)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Respicardia : anticoagulant (2016)

- BioControl : devices (2016)

- DC Device : devices (2016)

- Novartis : heart failure (2016)

- Cardiorentis : heart failure (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

27/30

Page 28: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Ponikowski Piotr - Bayer Healthcare : heart failure (2016)

- CIBIEM : heart failure (2016)

- Servier : heart failure, coronary artery disease (2016)

- Amgen : heart failure, lipids (2016)

Richter Dimitrios A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Menarini : CAD- hypertension (2016)

- Novartis : hypertension (2016)

- Abbott : lipids (2016)

- Amgen : lipids (2016)

- Sanofi Aventis : Lipids (2016)

- Lilly : Lipids (2016)

- Unilever : lipids (2016)

- Merck Sharp & Dohme : lipids (2016)

- Angelini : Lipids (2016)

- Vianex : lipids (2016)

- Galenica : Lipids (2016)

- Teva Pharmaceutical Industries : lipids, hypertension (2016)

- Swisspharma : lipids-hypertension (2016)

- Astra Zeneca : lipids-thrombosis (2016)

- Pfizer : lipids-thrombosis (2016)

- Winmedica : lipids-thrombosis (2016)

- Boehringer-Ingelheim : thrombosis (2016)

- Bayer Healthcare : Thrombosis (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

28/30

Page 29: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Roffi Marco A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Terumo Inc : coronary catheters (2016)

- Johnson & Johnson : coronary catheters (2016)

- Astra Zeneca : speaker fees related to the 2015 ESC NSTEMI GL (2016)

D - Research funding (departmental or institutional).- Boston Scientific : devices (2016)

- Medtronic : devices (2016)

- Biotronik : devices (2016)

- Terumo Inc : devices (2016)

- Abbott Vascular : devices (2016)

Shlyakhto Evgeny A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Krka Pharma : Arterial Hypertension (2016)

- Novartis : Arterial Hypertension, Heart Failure (2016)

- Merck Sharp & Dohme : Atherosclerosis (2016)

- Boehringer-Ingelheim : Dabigatran for Atrial Fibrillation (2016)

- Pfizer : General Cardiology (2016)

Simpson Iain A Nothing to be declared (2016)

Windecker Stephan D - Research funding (departmental or institutional).- Boston Scientific : General Cardiology (2016)

- St Jude Medical : General Cardiology (2016)

- Terumo Inc : General Cardiology (2016)

- Bracco Pharmaceutical : General Cardiology (2016)

Zamorano Gomez Jose Luis

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Philips : 3D Echocardiography. (2016)

- Servier : Clinical case presentation during ESC Cong 2016 (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conducted every January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up to and including 2016.

29/30

Page 30: (6& … · - Philips : 3D Echocardiography. (2016) - Servier : Clinical case presentation during ESC Cong 2016 (2016) - Pfizer : speaker CV risk factors. (2016) - MSD : speaker. CV

Zamorano Gomez Jose Luis

- Pfizer : speaker CV risk factors. (2016)

- MSD : speaker. CV risk factors (2016)

D - Research funding (departmental or institutional).- Edwards Lifesciences : Echo for TAVi assessment & Epidemiology of Ao stenosis (2016)

- Abbott : Epidemiology study of Mitral regurgitation (2016)

21/08/2017

Committee for Practice Guidelines 2016-2018 - MEMBERS

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts during the yearly call for declaration conductedevery January covering the previous calendar year. The calls for declaration are conducted during the period of development of these guidelines up toand including 2016.

30/30